Abstract
Abnormalities of immune function occur in hemophilic patients independently of HIV infection [1-3]. These abnormalities arise as a result of the treatment, since untreated hemophiliacs are unaffected. These defects develop during childhood and adolescence [4,5] but remain stable over long periods in adult life. Although abnormalities of almost every aspect of immune function have been described in treated hemophiliacs,they are milder than the immune defects observed in AIDS and are not associated with opportunist infection.
This work was supported by the Haemophilia Society, grant no. 431932, and the University of Liverpool grant no. RD5267.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Carr R, Edmond E, Prescott RJ, et al. Abnormalities of circulating lymphocyte subsets in haemophiliacs in an AIDS-free population. Lancet 1984;i: 1431–4.
Madhok R, Gracie A, Lowe GDO. Impaired cell mediated immunity in haemophilia in the absence of infection with human immunodeficiency virus. BrMedJ 1986;293:978–80.
Menitove JE, Aster RH, Casper JT, et al. T-lymphocyte subpopulations in patients with classical haemophilia treated with cryoprecipitate and lyophylised concentrates. NEngl JMed 1983;308:83–6.
Kessler CM, Schulof RS, Alibaster O, et al. Inverse correlation between age related abnormalities of T-cell immunity and circulating thymosin alpha-1 levels in haemophilia A. BrJ Haematol 1984;58:325–36.
Shannon BT, Roach J, Cheek-Luten M, Orosz C, Ruymann FB. Progressive change in lymphocyte distribution and degree of hypergammaglobulinaemia with age in children with hemophilia. JClin Immunol 1986;6: 121–9.
Froebel KS, Madhok R, Forbes CD, Lennie SE, Lowe GDO, Sturrock RD. Immunological abnormalities in haemophilia: Are they caused by American factor VIII concentrate? BrMedJ 1983;287:1091–3.
Brettler DB, Forsberg AD, Brewster F, Sullivan JL, Levine PH. Delayed cutaneous hypersensitivity reactions in hemophilic subjected treated with factor concentrate. AmJ Med 1986;81:607–11.
David J. Immune response mechanisms. In: Rubenstein E, Federman DD (eds). Scientific American Medicine. New York, NY: Scientific American Inc, 1987;111:1–15.
Matheson DS, Green BJ, Fritzler MJ, Poon MC, Bowen TJ, Hoar DI. Humoral immune response in patients with haemophilia. Clin Immunol Immunopathol 1987;4:41–50.
Mannhalter JW, Zlabinger GJ, Ahmad R, Zielinski CC, Schramm W, Eible MM. A functional defect in the early phase of the immune response observed in patients with haemophilia A. Clin Immunol Immunopathol 1986; 38:390–7.
Pasi KJ, Hill FGH. In vitro and in vivo inhibition of monocyte phagocytic function by factor VIII concentrates: Correlation with concentrate purity. BrJ Haematol 1990;76:88–93.
Eible MM, Ahmad R, Wolf HM, Linnau Y, Gotz E, Mannhalter JW. Acomponent of factor VIII preparations which can be separated from factor VIII activity down modulates human monocyte functions. Blood 1987;69:1153–60.
Lederman MM, Saunders C, Toosi Z, Lemon N, Everson B, Ratnoff OD. Antihaemophilic factor preparations inhibit lymphocyte proliferation and production of interleukin 2. JLab Clin Med 1986;107:471–8.
Madhok R, Gracie JA, Smith J, Lowe GDO, Forbes CD. Capacity to produce interleukin 2 is impaired in haemophilia in the absence and presence of HIV 1 infection. BrJ Haematol 1990;76:70–4.
Thorpe R, Dilger P, Dawson NJ, Barrowcliffe TW. Inhibition of interleukin-2 secretion by factor VIII concentrates: A possible cause of immunosuppression in haemophiliacs. BrJ Haematol 1989;71:387–91.
Smith KA. Interleukin 2. Annual Reviews of Immunology 1984;2:319–33.
Hay CRM, McEvoy P, Duggan-Keen M. Inhibition of lymphocyte IL2-receptor expression by factor VIII concentrate: A possible cause of immuno- suppression in haemophiliacs. BrJ Haematol 1990;75:278–81.
Burrows L, Tartter P. Effect of blood transfusion on colonic malignancy recurrence rate. Lancet 1982;ii:662–5.
Blumberg N, Heal JM, Murphy P. Association between transfusion of whole blood and recurrence of cancer. Br MedJ 1986;293:530–3.
Proud G, Shenton BK, Smith BM. Blood transfusion and renal transplantation.Br J Surgery 1979;66:678–82.
Aronson DL. Cause of death in haemophilia A patients in the United States from 1968 to 1979. AmJ Haematol 1988;27:7–12.
Rizza C, Spooner RJD. Treatment of haemophilia and related disorders in Britain and Northern Ireland during 1976–80: Report on behalf of the directors of haemophilia centres in the Untied Kingdom. Br MedJ 1983;286: 829–33.
Rosendaal FR, Varekamp I, Smit C, et al. Mortality and causes of death in Dutch haemophiliacs, 1973–86. BrJ Haematol 1989;71:71–6.
Madhok R, Lowe GDO, Forbes CD, Stewart CJR. Extranodal lymphoma in a haemophiliac negative for antibody to HIV-1. Br MedJ 1987;294:679–80.
Tartter PI, Quintero S, Barron DM. Perioperative blood transfusion asso- ciated with infectious complications after colorectal cancer operations. AM J Surgery 1986;152:479–82.
Dawes LG, Aprahamian C, Condoin RE, Malangoni MA. The risk of infec- tion after colon injury. Surgery 1986;100:796–803.
Green WB, DeGnore LT, White GC. Orthopaedic procedures and prognosis in hemophilic patients who are seropositive for human immunodeficiency virus. JBone Joint Surg 1990;72:2–11.
Beddal AC, Hill FGH, George RH, Williams MD, Al-Rubei K. Unusually high incidence of tuberculosis among boys with haemophilia during an out- break of the disease in hospital. Clin Path 1985;38:1163–5.
Hill JD, Stevenson JK. Tuberculosis in unvaccinated children, adolescents and young adults: A city epidemic. Br MedJ 1983;286:1471–3.
Ludlam CA, Tucker J, Steel CM, et al. Human T-lymphocyte virus typelll (HTLV-III) infection in seronegative haemophiliacs after transfusion of factor VIII. Lancet 1985;ii:233–6.
Hay CRM, Preston FE, Triger DR, Underwood JCE. Progressive liver disease in haemophilia: An understated problem? Lancet 1985;i: 1495–8.
Spero JA, Lewis JH, van Thiel DH, Hasiba U, Rabin BS. Asymptomatic structural liver disease in haemophiliacs. NEngl JMed 1978;31:779–83.
Koretz RL, Stone D, Gitnick GL. The long-term course of non-A, non-B hepatitis.Gastroenterology 1980;79:893–8.
Wright R, Millward-Sadler GH. Chornic hepatitis. In: Wright R, MillwardSadler GH, Alberti KGMM, Karran S (eds). Liver and biliary disease: Paîhophysiology,diagnosis and management. Baillière Tindall: Saunders Corp 1985:769–820.
Lee CA, Kernoff PBA, Karayiannis P, Farci P, Thomas HC. Interactions between hepatotropic viruses in patients with haemophilia. JHepatology 1985;1:379–84.
Margolick JB, Volkman DJ, Folks TM, Fauci AS. Amplification of HTLV- III/LAV infection by antigen-induced activation of T cells and direct suppression by virus of lymphocyte blastogenic responses. J Immunol 1987; 138:1719–23.
Brettler DB, Forsberg AD, Levine PH, Petillo J, Lamon K, Sullivan JL. Factor VIILC concentrate purified from plasma using monoclonal antibodies:Human studies. Blood 1989;73:1859–63.
Rocino A, Miraglia E, Mastrullo L, Quirino AA, Ziello L, De Biasi R. Prospective controlled trial of an ultra-pure factor VIII concentrate to evaluate the effects on immune status of HIV antibody-positive hemophilia patients (preliminary results). Estratto da: “Acta Toxicologica et Therapeutica” 1990;XI:(l):49–58.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1991 Springer Science+Business Media Dordrecht
About this chapter
Cite this chapter
Hay, C.R.M. (1991). The Effect of Chronic Exposure to Clotting Factor Concentrates on the Immune System. In: Sibinga, C.T.S., Das, P.C., Mannucci, P.M. (eds) Coagulation and Blood Transfusion. Developments in Hematology and Immunology, vol 26. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-3900-1_22
Download citation
DOI: https://doi.org/10.1007/978-1-4615-3900-1_22
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-6740-6
Online ISBN: 978-1-4615-3900-1
eBook Packages: Springer Book Archive